Precision Biosciences Inc Receivables Turnover Ratio (DTIL), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Precision Biosciences Inc  (NASDAQ: DTIL)
 

Precision Biosciences Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Precision Biosciences Inc's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 19.23, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Precision Biosciences Inc in Jun 30 2026 quarter, has decreased to 19 days, compared to 31 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Precision Biosciences Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Precision Biosciences Inc Selling?


What is Receivable Turnover Ratio?





DTIL Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change - -35.7 % - -3.57 % -8.19 %
Y / Y Revenue Change - 37272.41 % 5261.13 % -97.74 % -99.96 %
Receivable Turnover Ratio (TTM) 19.23 11.94 7.91 0.13 0.23
DTIL's Total Ranking # # # # #
Accounts Receivable average collection period days 19 31 46 2896 1618
Seq. Receivable Change - - - -6.21 % -7.89 %
Seq. Revenue Change - -68.31 % 263007.69 % -27.78 % -37.93 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 






Financial Statements
Precision Biosciences Inc's Accounts Receivable $ 0 Millions Visit DTIL's Balance sheet
Precision Biosciences Inc's Sales TTM $ 45 Millions Visit DTIL's Income Statement
Sources of DTIL's Revenues Visit DTIL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DTIL's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DTIL's Growth Rates DTIL's Roa DTIL's Inventory Turnover Ratio DTIL's Dividend Comparisons
DTIL's Profitability Ratios DTIL's Roi DTIL's Asset Turnover Ratio DTIL's Dividend Growth
DTIL's Valuation Ratios DTIL's Roe DTIL's Financial Strength Ratios DTIL's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026

Date modified: 2026-09-26T07:36:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.